UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Treatment patterns and outcomes with luspatercept in patients with lower‐risk myelodysplastic syndromes: A retrospective US cohort analysis

HemaSphere, 2024-01, Vol.8 (1), p.e38-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES RECEIVING LUSPATERCEPT IN ROUTINE CLINICAL PRACTICE IN THE UNITED STATES

HemaSphere, 2023-08, Vol.7 (S3), p.e648138a-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Even Optimists Get the Blues: Interindividual Consistency in the Tendency to Brace for the Worst

Journal of personality, 2017-12, Vol.85 (6), p.807-816

2017

Link zum Volltext

Verfügbarkeit prüfen

Differences in real-world (RW) non-small cell lung cancer (NSCLC) treatment patterns among people living with HIV/AIDS (PLWHA) compared to those without HIV/AIDS (PWoHA)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7070-7070

2020

Link zum Volltext

Verfügbarkeit prüfen

Differences in real-world liver cancer treatment patterns among people living with HIV/AIDS (PLWHA) compared to those without HIV/AIDS (PWoHA)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19010-e19010

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma

Future oncology (London, England), 2022-02, Vol.18 (5), p.553-564

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Gender in Worry and Efforts to Cope during Stressful Waiting Periods

Sex roles, 2019-12, Vol.81 (11-12), p.765-778

2019

Link zum Volltext

Verfügbarkeit prüfen

Is Waiting the Hardest Part? Comparing the Emotional Experiences of Awaiting and Receiving Bad News

Personality & social psychology bulletin, 2015-11, Vol.41 (11), p.1551-1559

2015

Link zum Volltext

Verfügbarkeit prüfen

Hematologic and transfusion outcomes in patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS) receiving luspatercept: Real-world assessment in the community practice setting

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7057-7057

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of Clinical Characteristics at Diagnosis with Outcomes in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from a Real-World Medical Chart Review in the US

Blood, 2022-11, Vol.140 (Supplement 1), p.10998-11000

2022

Link zum Volltext

Verfügbarkeit prüfen

Monitoring and management of interstitial lung disease/pneumonitis among patients with metastatic breast cancer treated with trastuzumab deruxtecan

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1036-1036

2022

Link zum Volltext

Verfügbarkeit prüfen

US physician perceptions of treatment decision making for advanced renal cell carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.311-311

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Luspatercept: An Evaluation of US Clinical Practice Utilization and Treatment Patterns

Blood, 2022-11, Vol.140 (Supplement 1), p.944-946

2022

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in treatment patterns and outcomes of first-line (1L) therapies for advanced renal cell carcinoma (aRCC) in the real-world (RW) setting

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4548-4548

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world erythropoiesis-stimulating agent (ESA) treatment patterns and outcomes among U.S. patients with lower-risk myelodysplastic syndromes (LR-MDS)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19065-e19065

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Correlates of Word Use in Physician-Patient Communication

Annals of behavioral medicine, 2016-10, Vol.50 (5), p.664-677

2016

Link zum Volltext

Verfügbarkeit prüfen

Lower-Risk Myelodysplastic Syndromes: Erythropoiesis-Stimulating Agent Treatment Approaches and Outcomes in the United States

Blood, 2021-11, Vol.138 (Supplement 1), p.4657-4657

2021

Link zum Volltext

Verfügbarkeit prüfen

POSTER: MDS-065 Treatment Patterns and Transfusion Outcomes Among Erythropoietin-Stimulating Agent (ESA)-Naïve Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in Routine Clinical Practice in the United States (US)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S180-S180

2023

Link zum Volltext

Verfügbarkeit prüfen

MDS-065 Treatment Patterns and Transfusion Outcomes Among Erythropoietin-Stimulating Agent (ESA)-Naïve Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in Routine Clinical Practice in the United States (US)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S352-S353

2023

Link zum Volltext

Verfügbarkeit prüfen

Racial disparity in uterine cancer treatment and survival: A matter of Black women’s lives

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6550-6550

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

The oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.414-424

2023

Link zum Volltext

Verfügbarkeit prüfen

Two Definitions of Waiting Well

Emotion (Washington, D.C.), 2016-02, Vol.16 (1), p.129-143

2016

Link zum Volltext

Verfügbarkeit prüfen

Focusing on Future Forecasts: A Comprehensive Examination of Performance Expectations

Falkenstein, Angelica R

2018

Link zum Volltext
ProQuest

Waiting for Health News

The Wiley Encyclopedia of Health Psychology, 2020, p.781-788

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment patterns and outcomes with luspatercept in patients with lower‐risk myelodysplastic syndromes: A retrospective US cohort analysis

P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES RECEIVING LUSPATERCEPT IN ROUTINE CLINICAL PRACTICE IN THE UNITED STATES

Even Optimists Get the Blues: Interindividual Consistency in the Tendency to Brace for the Worst

Differences in real-world (RW) non-small cell lung cancer (NSCLC) treatment patterns among people living with HIV/AIDS (PLWHA) compared to those without HIV/AIDS (PWoHA)

Differences in real-world liver cancer treatment patterns among people living with HIV/AIDS (PLWHA) compared to those without HIV/AIDS (PWoHA)

Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma

The Role of Gender in Worry and Efforts to Cope during Stressful Waiting Periods

Is Waiting the Hardest Part? Comparing the Emotional Experiences of Awaiting and Receiving Bad News

Hematologic and transfusion outcomes in patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS) receiving luspatercept: Real-world assessment in the community practice setting

Association of Clinical Characteristics at Diagnosis with Outcomes in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Erythropoiesis Stimulating Agents (ESAs): Findings from a Real-World Medical Chart Review in the US

Monitoring and management of interstitial lung disease/pneumonitis among patients with metastatic breast cancer treated with trastuzumab deruxtecan

US physician perceptions of treatment decision making for advanced renal cell carcinoma

Real-World Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated with Luspatercept: An Evaluation of US Clinical Practice Utilization and Treatment Patterns

Racial differences in treatment patterns and outcomes of first-line (1L) therapies for advanced renal cell carcinoma (aRCC) in the real-world (RW) setting

Real-world erythropoiesis-stimulating agent (ESA) treatment patterns and outcomes among U.S. patients with lower-risk myelodysplastic syndromes (LR-MDS)

Characteristics and Correlates of Word Use in Physician-Patient Communication

Lower-Risk Myelodysplastic Syndromes: Erythropoiesis-Stimulating Agent Treatment Approaches and Outcomes in the United States

POSTER: MDS-065 Treatment Patterns and Transfusion Outcomes Among Erythropoietin-Stimulating Agent (ESA)-Naïve Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in Routine Clinical Practice in the United States (US)

MDS-065 Treatment Patterns and Transfusion Outcomes Among Erythropoietin-Stimulating Agent (ESA)-Naïve Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in Routine Clinical Practice in the United States (US)

Racial disparity in uterine cancer treatment and survival: A matter of Black women’s lives

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

Two Definitions of Waiting Well

Focusing on Future Forecasts: A Comprehensive Examination of Performance Expectations

Waiting for Health News

Suchergebnisse filtern